Comparative Study of Regional Nerve Blocks in Primary Cleft Palate Repair
This study will evaluate whether adding a suprazygomatic maxillary nerve block to the standard palatal nerve block improves pain control after cleft palate repair surgery in children. Participants will be randomly assigned to receive either the standard palatal block alone or the standard palatal block combined with a suprazygomatic maxillary nerve block. Both techniques use medications commonly used for pain management during surgery.
The purpose of this study is to determine whether the addition of the suprazygomatic maxillary nerve block reduces postoperative pain, decreases the need for opioid medications, and improves recovery after cleft palate repair. Researchers will compare pain scores, medication use, recovery outcomes, and any treatment-related complications between the two groups.
Information collected from this study may help identify the most effective regional anesthesia approach for children undergoing cleft palate repair and may improve postoperative pain management and patient recovery.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Logan Stratton
- Telefonnummer: 443-922-6012
- E-post: lstratton@childrensnational.org
Studer Kontakt Backup
- Navn: Albert Oh
- Telefonnummer: 202-713-8856
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Children undergoing primary cleft palate repair or secondary velopharyngeal insufficiency (VPI) surgery.
- Eligible to receive regional anesthetic nerve blocks as part of the planned surgical procedure.
- Parent or legal guardian able and willing to provide informed consent.
- Participant meets all institutional and surgical criteria for undergoing the planned procedure.
Exclusion Criteria:
- Known allergy, hypersensitivity, or contraindication to the study anesthetic medications.
- Medical conditions that contraindicate regional anesthetic nerve block procedures.
- Coagulopathy or bleeding disorder that would increase the risk of nerve block placement.
- Active infection at or near the planned injection site.
- Inability of parent or legal guardian to provide informed consent.
- Any condition that, in the opinion of the investigator, would make participation unsafe or interfere with study assessments.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Standard Palatal Nerve Block
Participants receive the standard palatal nerve block performed during cleft palate surgery. |
Regional anesthetic block of the palate performed during cleft palate or velopharyngeal insufficiency surgery using local anesthetic. This procedure serves as the standard pain management approach and is intended to provide perioperative analgesia and reduce postoperative pain. |
|
Eksperimentell: Standard Palatal Nerve Block Plus Suprazygomatic Maxillary Nerve Block
Participants receive the standard palatal nerve block plus a suprazygomatic maxillary nerve block during cleft palate surgery. |
Regional anesthetic block of the maxillary nerve performed via a suprazygomatic approach using local anesthetic in addition to the standard palatal nerve block. The procedure is intended to enhance perioperative analgesia, decrease postoperative pain, and reduce postoperative opioid requirements following cleft palate or velopharyngeal insufficiency surgery. |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative Pain Scores Measured by the Face, Legs, Activity, Cry, Consolability (FLACC) Scale
Tidsramme: Within the first 24 hours following surgery
|
Postoperative pain will be assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale following cleft palate repair or velopharyngeal insufficiency surgery. The FLACC scale rates five behavioral categories (Face, Legs, Activity, Cry, and Consolability) from 0 to 2 each, for a total score ranging from a minimum of 0 to a maximum of 10. Higher scores indicate more pain and therefore a worse outcome. Pain scores will be compared between participants receiving a standard palatal nerve block and those receiving a standard palatal nerve block plus a suprazygomatic maxillary nerve block to evaluate the effectiveness of the additional regional anesthesia technique. |
Within the first 24 hours following surgery
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative Opioid Consumption
Tidsramme: Within the first 24 hours following surgery
|
Total postoperative opioid medication use will be recorded and compared between participants receiving a standard palatal nerve block and those receiving a standard palatal nerve block plus a suprazygomatic maxillary nerve block. This outcome will assess whether the additional regional anesthesia technique reduces the need for opioid analgesics following surgery. |
Within the first 24 hours following surgery
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Nevrologiske manifestasjoner
- Munnsykdommer
- Stomatognatiske sykdommer
- Sykdommer i nervesystemet
- Postoperative komplikasjoner
- Patologiske prosesser
- Nevroatferdsmanifestasjoner
- Stomatognatiske systemabnormiteter
- Medfødte abnormiteter
- Leppe sykdommer
- Perseptuelle forstyrrelser
- Munnavvik
- Medfødte, arvelige og neonatale sykdommer og abnormiteter
- Patologiske tilstander, tegn og symptomer
- Tegn og symptomer
- Agnosia
- Leppespalte
- Kirurgisk såravfall
Andre studie-ID-numre
Andre studie-ID-numre
- STUDY00001302
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Individual participant data will not be shared with researchers outside of the study team. Data collected for this study contain protected health information and were obtained under informed consent and institutional review board requirements that do not include plans for external sharing of individual participant-level data.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .